Dr. Abbey Discusses the New Era of Geographic Atrophy Management
Texas Retina’s Ashkan M. Abbey, MD, recently participated in a three-part special report video series by Ophthalmology Times that examined the evolving treatment landscape for geographic atrophy (GA). What is Geographic Atrophy?
read more
Getting to Know Ocular Oncologist Timothy S. Fuller, MD
May is Ocular Melanoma Awareness Month. Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina Associates, we have
read more
Our Offices Will Close for Memorial Day
All Texas Retina offices will be closed on Monday, May 25, in observance of Memorial Day. We remember and honor all those who gave their lives in service to our country.
read more
Dr. Abbey Presented on Retinal Sustained Drug Delivery Research at Retina World Congress
At the recently held Retina World Congress 2026 meeting, Texas Retina’s Dallas Director of Clinical Research Ashkan M. Abbey, MD, presented on the evolving clinical trial landscape for sustained drug delivery in retinal disease. Dr.
read more
May is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease. It involves the iris, ciliary body, and/or choroid, which are collectively referred to as the uvea, and the tumors develop in the pigmented
read more Dr. Abbey Discusses Retinal Vein Occlusion as a Marker of Systemic Risk
Texas Retina’s Ashkan Abbey, MD, recently appeared on the ReachMD podcast to discuss “Retinal Vein Occlusion as a Marker of Systemic Risk.” This was the third episode he contributed to their “Eye
read more
May is Healthy Vision Month: 10 Steps to Protect Your Eyes
You may have heard that the eyes are the window to the soul, but did you know they’re also a window to your health? Protecting your overall health can go a long
read more
New Clinical Trials Available at Texas Retina
At Texas Retina, we remain committed to conducting ongoing research that will continue to advance retinal care — a value instilled by the pioneering physicians who founded our practice more than 50
read more
Texas Retina Team Publishes Results of COED Trial for Diabetic Macular Edema
A prospective, randomized, comparative trial conducted exclusively at Texas Retina, the COED study compared two treatment regimens for diabetic macular edema (DME): a combination of an intravitreal dexamethasone implant (Ozurdex) and aflibercept
read more
What to Expect from a Fluorescein Angiography Test
At Texas Retina, our retina specialists use fluorescein angiography (FA) to help diagnose and monitor a number of retinal diseases and conditions, including age-related macular degeneration, diabetic retinopathy, central serous retinopathy, macular
read more